EUCTR2011-002135-26-ITActive, not recruitingNot Applicable
Efficacy and Safety of Acyclovir 5 Lipstick (Contra) in Treatment of Skin Infections Provoked by Herpes Simplex. A Randomised, Double-blind, Placebo Controlled, Parallel Group Study. - 4PH/2011/002
AESCULAPIUS FARMACEUTICI S.R.L.0 sitesStarted: December 27, 2011Last updated:
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Caucasian origin; - Patients with a clinical diagnosis of active infection of recurrent labial herpes in prodromal phase; - Body weight within 20% of ideal body weight; - Normal physical examination, vital signs, ECG; - Negative result of pregnancy test for female patients.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
Exclusion Criteria
- •? Recent infection of Herpes Zoster in the last 4 weeks; ? Treatment with other systemic or topical antiviral agents or systemic corticosteroids within 4 weeks prior to study drug administration; ? Previous herpes vaccine; ? Pregnant, nursing and/or lactating females; ? Patients with herpetic stomatitis; ? Patients with severe symptoms or signs of herpes labialis such as intraoral lesions or lesions in the nostrils; - Subjects with lesions wider than 2.0cm2; - Subjects with renal, hepatic or metabolic dysfunction that may pose a risk to the safety;
Investigators
Similar Trials
Completed
Phase 3
Clinical and Microbiological Effects of 2/5% Acyclovir Gelchronic periodontitis.Chronic periodontitisIRCT138801231809N1Dental School, Shiraz University of Medical Sciences18
Not yet recruiting
Phase 3
Efficacy of Acyclovir in Pityriasis roseaPityriasis roseaPityriasis rosea.IRCT20210823052264N2PNS SHIFA60
Completed
Phase 2
Efficacy of antiviral medications in controlling vertigo attacks of patients with Meniere's DiseaseMeniere's disease.Labyrinthine hydrops Ménière's syndrome or vertigoIRCT138901023597N1Vice Chancellor of Research, Tehran University of Medical Sciences80
Not yet recruiting
Phase 3
Effectiveness of Oral Acyclovir in Treatment of Infectious Mononucleosis in ChildreInfectious Mononucleosis.Cytomegaloviral mononucleosis, without complicationsB27.10IRCT20201201049554N1Gorgan University of Medical Sciences46
Active, not recruiting
Not Applicable
Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, multicentre trial. - NAGenito-anal herpes simplex infectionsEUCTR2005-001705-26-DESpirig Pharma AG200
